177 related articles for article (PubMed ID: 3833119)
21. Increased metastatic capacity of Lewis lung tumor cells by in vivo selection procedure.
Pál K; Kopper L; Lapis K
Invasion Metastasis; 1983; 3(3):174-82. PubMed ID: 6677625
[TBL] [Abstract][Full Text] [Related]
22. Lewis lung carcinoma in mice as an experimental therapy model. II. The effect of BCNU, cyclophosphamide and/or surgery treatment on early and advanced tumor in mice.
Budzyński W
Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):373-7. PubMed ID: 7184488
[TBL] [Abstract][Full Text] [Related]
23. Indirect effect of cyclophosphamide on the lung tumor colony formation and on the conditioned media activity.
Janik P; Szaniawska B
Neoplasma; 1984; 31(1):37-42. PubMed ID: 6700793
[TBL] [Abstract][Full Text] [Related]
24. Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice.
Pearlstein E; Ambrogio C; Karpatkin S
Cancer Res; 1984 Sep; 44(9):3884-7. PubMed ID: 6744304
[TBL] [Abstract][Full Text] [Related]
25. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
Milas L; Ito H; Hunter N
Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
[TBL] [Abstract][Full Text] [Related]
26. Relationship between primary tumor volume and lung metastasis in Lewis lung carcinoma (1). Assay for time course of development of metastasis.
Ohizumi Y; Maezawa H; Mori T
Tokai J Exp Clin Med; 1987 Nov; 12(4):229-35. PubMed ID: 3503392
[TBL] [Abstract][Full Text] [Related]
27. [Experiment to potentiate the effect of cyclophosphamide combined with tempidon and caffeine in leukemia L1210 and Lewis hepatic carcinoma].
Stoichkov I; Milushev A; Todorov D
Eksp Med Morfol; 1978; 17(1):9-14. PubMed ID: 639751
[TBL] [Abstract][Full Text] [Related]
28. Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity.
Gorelik E; Segal S; Feldman M
J Natl Cancer Inst; 1980 Dec; 65(6):1257-64. PubMed ID: 6933271
[TBL] [Abstract][Full Text] [Related]
29. [Recombinant tumor necrosis factor promotes the formation of hematogenic metastases to the lungs of C57Bl/6 mice].
Kudriavets IuI; Didkovskaia LP
Eksp Onkol; 1990; 12(2):47-50. PubMed ID: 2318134
[TBL] [Abstract][Full Text] [Related]
30. Hematopoietic rescue via T-cell-dependent, endogenous granulocyte-macrophage colony-stimulating factor induced by the pineal neurohormone melatonin in tumor-bearing mice.
Maestroni GJ; Covacci V; Conti A
Cancer Res; 1994 May; 54(9):2429-32. PubMed ID: 8162592
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
[TBL] [Abstract][Full Text] [Related]
32. Effect of cyclophosphamide or x-rays on spontaneously occurring metastases from tumors transplanted into the tails of mice.
Travis EL; Reinartz G; Chu AM; Down JD; Fowler JF
Cancer Res; 1981 May; 41(5):1803-7. PubMed ID: 7214347
[TBL] [Abstract][Full Text] [Related]
33. Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor alpha enhancement of experimental metastasis.
Okahara H; Yagita H; Miyake K; Okumura K
Cancer Res; 1994 Jun; 54(12):3233-6. PubMed ID: 7515767
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of experimental lung metastases of Lewis lung carcinoma cells by chemically modified heparin with reduced anticoagulant activity.
Yoshitomi Y; Nakanishi H; Kusano Y; Munesue S; Oguri K; Tatematsu M; Yamashina I; Okayama M
Cancer Lett; 2004 Apr; 207(2):165-74. PubMed ID: 15072825
[TBL] [Abstract][Full Text] [Related]
35. Effect of cyclophosphamide on survival of mice and incidence of metastatic tumor following intravenous and intracardial inoculation of tumor cells.
Vollmer TL; Conley FK
Cancer Res; 1984 Sep; 44(9):3902-6. PubMed ID: 6744306
[TBL] [Abstract][Full Text] [Related]
36. In vivo isolation of a metastatic tumor cell variant involving selective and nonadaptive processes.
Raz A; Hanna N; Fidler IJ
J Natl Cancer Inst; 1981 Jan; 66(1):183-9. PubMed ID: 6935459
[TBL] [Abstract][Full Text] [Related]
37. [Xenograft of human bronchial squamous cell carcinoma and its sensitivity to therapy].
Bak M; Sugár J
Orv Hetil; 1984 Dec; 125(52):3161-4, 3167. PubMed ID: 6549406
[No Abstract] [Full Text] [Related]
38. The effect of cyclophosphamide on artificial metastases formation in the lungs of Balb/c mice.
Szaniawska B; Janik P
Arch Immunol Ther Exp (Warsz); 1984; 32(3):337-43. PubMed ID: 6525028
[TBL] [Abstract][Full Text] [Related]
39. Angiostatin potentiates cyclophosphamide treatment of metastatic disease.
Mauceri HJ; Seetharam S; Beckett MA; Schumm LP; Koons A; Gupta VK; Park JO; Manan A; Lee JY; Montag AG; Kufe DW; Weichselbaum RR
Cancer Chemother Pharmacol; 2002 Nov; 50(5):412-8. PubMed ID: 12439600
[TBL] [Abstract][Full Text] [Related]
40. A quantitative model for the study of the growth and treatment of a tumor and its metastases with correlation between proliferative state and sensitivity to cyclophosphamide.
DeWys WD
Cancer Res; 1972 Feb; 32(2):367-73. PubMed ID: 5058192
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
